Susan E Graf - Net Worth and Insider Trading
Susan E Graf Net Worth
The estimated net worth of Susan E Graf is at least $2,004 dollars as of 2024-11-29. Susan E Graf is the Director of Finch Therapeutics Group Inc and owns about 167 shares of Finch Therapeutics Group Inc (FNCH) stock worth over $2,004. Details can be seen in Susan E Graf's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan E Graf has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susan E Graf
Susan E Graf Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan E Graf owns 2 companies in total, including Epizyme Inc (EPZM) , and Finch Therapeutics Group Inc (FNCH) .
Click here to see the complete history of Susan E Graf’s form 4 insider trades.
Insider Ownership Summary of Susan E Graf
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EPZM | Epizyme Inc | 2016-04-25 | Chief Business Officer |
FNCH | Finch Therapeutics Group Inc | 2023-06-09 | director |
Susan E Graf Latest Holdings Summary
Susan E Graf currently owns a total of 1 stock. Susan E Graf owns 167 shares of Finch Therapeutics Group Inc (FNCH) as of June 9, 2023, with a value of $2,004.
Latest Holdings of Susan E Graf
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FNCH | Finch Therapeutics Group Inc | 2023-06-09 | 167 | 12.00 | 2,004 |
Holding Weightings of Susan E Graf
Susan E Graf Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan E Graf has made a total of 1 transactions in Finch Therapeutics Group Inc (FNCH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Finch Therapeutics Group Inc is the acquisition of 167 shares on June 9, 2023, which cost Susan E Graf around $1,353.
Insider Trading History of Susan E Graf
- 1
Susan E Graf Trading Performance
GuruFocus tracks the stock performance after each of Susan E Graf's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan E Graf is -23.86%. GuruFocus also compares Susan E Graf's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan E Graf within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Susan E Graf's insider trading performs compared to the benchmark.
Performance of Susan E Graf
Susan E Graf Ownership Network
Susan E Graf Owned Company Details
What does Epizyme Inc do?
Who are the key executives at Epizyme Inc?
Susan E Graf is the Chief Business Officer of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .
Epizyme Inc (EPZM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Epizyme Inc Insider Transactions
Susan E Graf Mailing Address
Above is the net worth, insider trading, and ownership report for Susan E Graf. You might contact Susan E Graf via mailing address: 400 Technology Square, 4th Floor, Cambridge Ma 02139.